[go: up one dir, main page]

GB9226860D0 - Novel treatment - Google Patents

Novel treatment

Info

Publication number
GB9226860D0
GB9226860D0 GB929226860A GB9226860A GB9226860D0 GB 9226860 D0 GB9226860 D0 GB 9226860D0 GB 929226860 A GB929226860 A GB 929226860A GB 9226860 A GB9226860 A GB 9226860A GB 9226860 D0 GB9226860 D0 GB 9226860D0
Authority
GB
United Kingdom
Prior art keywords
novel treatment
novel
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929226860A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Priority to GB929226860A priority Critical patent/GB9226860D0/en
Publication of GB9226860D0 publication Critical patent/GB9226860D0/en
Priority to NZ259318A priority patent/NZ259318A/en
Priority to AU58088/94A priority patent/AU678800B2/en
Priority to CA002150827A priority patent/CA2150827A1/en
Priority to PCT/DK1993/000426 priority patent/WO1994014453A1/en
Priority to EP94903742A priority patent/EP0675722A1/en
Priority to JP6514698A priority patent/JPH08504776A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
GB929226860A 1992-12-23 1992-12-23 Novel treatment Pending GB9226860D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB929226860A GB9226860D0 (en) 1992-12-23 1992-12-23 Novel treatment
NZ259318A NZ259318A (en) 1992-12-23 1993-12-17 Use of vitamin d analogues in the treatment of steroid-induced skin atrophy
AU58088/94A AU678800B2 (en) 1992-12-23 1993-12-17 Hydroxy vitamin D3 compounds for treating skin atrophy
CA002150827A CA2150827A1 (en) 1992-12-23 1993-12-17 Hydroxy vitamin d3 compounds for treating skin atrophy
PCT/DK1993/000426 WO1994014453A1 (en) 1992-12-23 1993-12-17 Hydroxy vitamin d3 compounds for treating skin atrophy
EP94903742A EP0675722A1 (en) 1992-12-23 1993-12-17 Hydroxy vitamin d3 compounds for treating skin atrophy
JP6514698A JPH08504776A (en) 1992-12-23 1993-12-17 Hydroxyvitamin D3 compounds for treating skin atrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226860A GB9226860D0 (en) 1992-12-23 1992-12-23 Novel treatment

Publications (1)

Publication Number Publication Date
GB9226860D0 true GB9226860D0 (en) 1993-02-17

Family

ID=10727144

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929226860A Pending GB9226860D0 (en) 1992-12-23 1992-12-23 Novel treatment

Country Status (7)

Country Link
EP (1) EP0675722A1 (en)
JP (1) JPH08504776A (en)
AU (1) AU678800B2 (en)
CA (1) CA2150827A1 (en)
GB (1) GB9226860D0 (en)
NZ (1) NZ259318A (en)
WO (1) WO1994014453A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195431T1 (en) * 1993-09-01 2000-09-15 Teijin Ltd EMULSION BASED ON 1-ALPHA,24-DIHYDROXY-VITAMIN D3
EP0711558A1 (en) * 1994-10-21 1996-05-15 Unilever Plc Compositions for topical application to skin, hair and nails
DE19744127B4 (en) 1997-10-01 2006-10-05 Schering Ag New vitamin D derivatives with side-chain cyclopropyl rings, processes and intermediates for their preparation and their use in the manufacture of medicaments
KR20010032892A (en) * 1997-12-09 2001-04-25 나가야마 오사무 Creams containing vitamin d3 derivatives
KR100491202B1 (en) * 1998-03-04 2005-05-25 데이진 가부시키가이샤 Activated vitamin D3 emulsion-type lotions
HU230045B1 (en) * 1999-04-23 2015-06-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Pharmaceutical composition for dermal use
CN1449289A (en) * 2000-08-30 2003-10-15 中外制药株式会社 OCT preparation
PT1331927E (en) * 2000-10-27 2008-01-30 Leo Pharma As Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
CN101596191B (en) 2001-01-26 2011-06-15 中外制药株式会社 Method for treatment of disease using malonyl-coa decarboxylase inhibitor
EP1353662B1 (en) 2001-01-26 2007-04-18 Chugai Seiyaku Kabushiki Kaisha Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
ES2274005T3 (en) 2001-01-26 2007-05-16 Chugai Seiyaku Kabushiki Kaisha MALONYL-COA DECARBOXYLASE INHIBITORS USED AS METABOLIC MODULATORS.
US7709510B2 (en) 2001-02-20 2010-05-04 Chugai Seiyaku Kabushiki Kaisha Azoles as malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
ATE442141T1 (en) 2001-02-20 2009-09-15 Chugai Pharmaceutical Co Ltd METHOD FOR TREATING METABOLIC DISEASES USING MALONYL COA DECARBOXYLASE INHIBITORS
CA2533763C (en) 2003-08-01 2012-11-20 Chugai Seiyaku Kabushiki Kaisha Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors
ES2353306T3 (en) 2003-08-01 2011-03-01 Chugai Seiyaku Kabushiki Kaisha USEFUL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MALONIL-COA-DESCARBOXYLASE.
ES2309563T3 (en) 2003-08-01 2008-12-16 Chugai Seiyaku Kabushiki Kaisha PIPERIDINE COMPOUNDS USED AS INHIBITORS FROM MALONIL COENZIMA TO DESCARBOXYLASE.
DE602004016530D1 (en) 2003-08-01 2008-10-23 Chugai Pharmaceutical Co Ltd CYANOGUANIDIN-BASED AZOL COMPOUNDS AS MALONYL-COA DECARBOXYLASE HEMMER
GB0513984D0 (en) * 2005-07-07 2005-08-17 Teva Pharma Dosage form
JP2010502624A (en) * 2006-08-29 2010-01-28 テバ ファーマシューティカル インダストリーズ リミティド Stable pharmacologically active composition comprising a corticosteroid compound having a low pH affinity and a vitamin D-containing compound
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
KR101641372B1 (en) * 2015-05-08 2016-07-20 (주)동구바이오제약 A pharmaceutical formulation which shows enhanced stability and skin permeability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015774D0 (en) * 1990-07-18 1990-09-05 Leo Pharm Prod Ltd Novel treatment
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9214202D0 (en) * 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
NZ259318A (en) 1997-08-22
JPH08504776A (en) 1996-05-21
AU678800B2 (en) 1997-06-12
EP0675722A1 (en) 1995-10-11
CA2150827A1 (en) 1994-07-07
AU5808894A (en) 1994-07-19
WO1994014453A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
GB9215633D0 (en) Novel treatment
GB9208339D0 (en) Treatment composition
GB9127150D0 (en) Novel treatment
GB9226860D0 (en) Novel treatment
GB9211148D0 (en) Novel treatment
GB9203039D0 (en) Treatment
GB9225860D0 (en) Novel treatment
GB9226957D0 (en) Novel treatment
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
AP9300527A0 (en) Novel treatment
GB9203637D0 (en) Novel treatment
GB9225859D0 (en) Novel treatment
GB9225881D0 (en) Novel treatment
GB9214209D0 (en) Novel treatment
GB9225963D0 (en) Novel treatment
GB9225861D0 (en) Novel treatment
GB9225959D0 (en) Novel treatment
GB9225862D0 (en) Novel treatment
GB9225956D0 (en) Novel treatment
GB9225948D0 (en) Novel treatment
AP9200456A0 (en) Novel treatment
GB9225863D0 (en) Novel treatment
GB9225961D0 (en) Novel treatment
GB9225858D0 (en) Novel treatment
GB9225857D0 (en) Novel treatment